Kenvue, the household staple behind Tylenol, has inked a deal to sell itself to Kimberly-Clark in a $48.7 billion deal. The ...

Exchange-traded funds (ETFs) have been siphoning assets away from mutual funds for literally decades now. You can chalk that ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.